MD HB779

Establishes medication review committees within the Department of Public Safety and Correctional Services to approve involuntary administration of psychotropic medication to incarcerated individuals who refuse treatment in non-emergency situations

Prohibits administering psychotropic medication to refusing inmates except in emergencies (immediate danger to self/others) or when a committee approves it after finding the individual has a mental disorder causing likelihood of serious harm and has refused informed consent

Requires committees to consist of three members appointed by the Director of Mental Health: the regional chief psychiatrist, another psychiatrist, and a non-physician mental health professional; individuals involved in the inmate's treatment cannot serve

Guarantees incarcerated individuals at least 5 business days written notice before committee meetings, the right to attend hearings, present witnesses, ask questions, receive a lay advisor, and request administrative review within 2 business days of an adverse decision

Limits involuntary medication approval to a maximum of 90 days, requires treating physicians to document medication benefits and side effects every 15 days, and takes effect October 1, 2025